Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Przeglądasz jako GOŚĆ
Tytuł pozycji:

Association of Padua prediction score with in-hospital prognosis in COVID-19 patients.

Tytuł :
Association of Padua prediction score with in-hospital prognosis in COVID-19 patients.
Autorzy :
Zeng, D X
Xu, J L
Mao, Q X
Liu, R
Zhang, W Y
Qian, H Y
Xu, L
Pokaż więcej
Temat :
COVID-19
SARS-CoV-2
FORECASTING
THROMBOEMBOLISM
LOGISTIC regression analysis
Źródło :
QJM: An International Journal of Medicine; Nov2020, Vol. 113 Issue 11, p789-793, 5p
Czasopismo naukowe
Background Nearly 20% novel coronavirus disease 2019 (COVID-19) patients have abnormal coagulation function. Padua prediction score (PPS) is a validated tools for venous thromboembolism (VTE) risk assessment. However, its clinical value in COVID-19 patients' evaluation was unclear. Methods We prospectively evaluated the VTE risk of COVID-19 patients using PPS. Demographic and clinical data were collected. Association of PPS with 28-day mortality was analyzed by multivariate logistic regression and Kaplan–Meier analysis. Results Two hundred and seventy-four continuous patients were enrolled, with total mortality of 17.2%. Patients in high PPS group, with significantly abnormal coagulation, have a higher levels of interleukin 6 (25.27 vs. 2.55 pg/ml, P  < 0.001), prophylactic anticoagulation rate (60.7% vs. 6.5%, P  <   0.001) and mortality (40.5% vs. 5.9%, P  <   0.001) when compared with that in low PPS group. Critical patients showed higher PPS (6 vs. 2 score, P  <   0.001) than that in severe patients. Multivariate logistic regression revealed the independent risk factors of in-hospital mortality included high PPS [odds ratio (OR): 7.35, 95% confidence interval (CI): 3.08–16.01], increased interleukin-6 (OR: 11.79, 95% CI: 5.45–26.20) and elevated d-dimer (OR: 4.65, 95% CI: 1.15–12.15). Kaplan–Meier analysis indicated patients with higher PPS had a significant survival disadvantage. Prophylactic anticoagulation in higher PPS patients shows a mild advantage of mortality but without statistical significance (37.1% vs. 45.7%, P  =   0.42). Conclusion Higher PPS associated with in-hospital poor prognosis in COVID-19 patients. Prophylactic anticoagulation showed a mild advantage of mortality in COVID-19 patients with higher PPS, but it remain to need further investigation. [ABSTRACT FROM AUTHOR]
Copyright of QJM: An International Journal of Medicine is the property of Oxford University Press / USA and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies